CD8A and cancer: Since the expression of TIGIT and PDCD1 on the CD8 T cells are widely used to identify dysfunction or early activated effector T cells in several cancer types such as bladder cancer, these markers alone are insufficient to define terminally exhausted CD8+ T cell in CRC (37).